Pharmacological target therapy of neuropathic pain and patient-reported outcomes in patients with chronic low back pain in Korea: Results from the NLBP Outcomes Research

Medicine
Jae Taek HongJuneyoung Lee

Abstract

A number of studies have demonstrated an association of neuropathic pain and chronic low back pain (CLBP), but the outcome difference in each medical management is poorly understood. This study is aimed to investigate treatment patterns of neuropathic pain in CLBP patients and to explore patient-reported outcomes (PROs) including quality of life (QoL) and functional disability by treatment patterns.Data were extracted from the neuropathic low back pain (NLBP) outcomes research. It was a multicenter and cross-sectional study in which 1200 patients were enrolled at 27 general hospitals, from 2014 to 2015. Of total, 478 patients classified as neuropathic pain were used for this subgroup analysis. The patients were divided into 2 groups according to treatment patterns (with vs. without the targeted therapy [TT] of neuropathic pain). Demographic and clinical features were collected by chart reviews and PROs were measured by patient's survey. QoL was assessed by EuroQoL 5-dimension (EQ-5D) questionnaire. Functional disability was measured by the Quebec Back Pain Disability Scale (QBPDS). Multiple linear regression analyses were conducted to compare the PROs between TT group and non-targeted therapy (nTT) group.Among the NLBP patients...Continue Reading

References

Nov 4, 2000·Neurology·S H Sindrup, T S Jensen
Sep 9, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Samuli I SaarniJouko Lönnqvist
Oct 7, 2006·Current Medical Research and Opinion·Rainer FreynhagenThomas R Tölle
Mar 21, 2007·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·D E MoulinUNKNOWN Canadian Pain Society
Apr 11, 2009·PLoS Medicine·Joachim ScholzClifford J Woolf
Mar 17, 2010·Mayo Clinic Proceedings·Robert H DworkinChristopher D Wells
Jun 23, 2010·Clinical and Experimental Nephrology·Reiko TajimaKunihiro Yamagata
Nov 19, 2010·Current Medical Research and Opinion·Bart Morlion
Mar 15, 2011·Pain·Iain D BeithThomas J Chestnut
Apr 29, 2011·Rheumatology International·Dieu-Donné OuédraogoJoseph Y Drabo
Jul 26, 2011·The Journal of Pain : Official Journal of the American Pain Society·Nadine AttalDidier Bouhassira
Oct 24, 2012·Clinical Rheumatology·Yasuhiko HirabayashiUNKNOWN Michinoku Tocilizumab Study Group
Nov 7, 2012·The International Journal of Neuroscience·Tomas Uher, Petr Bob
Jul 12, 2013·PloS One·Matti FörsterRalf Baron
Dec 7, 2013·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Toshihiko YamashitaShin-ichi Kikuchi
Dec 17, 2014·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Akihiko HiyamaJoji Mochida
Jun 13, 2015·Yonsei Medical Journal·Si Young ParkJin Ho Jeon
Mar 5, 2016·European Journal of Pain : EJP·R BaronR-D Treede
May 31, 2016·Topics in Stroke Rehabilitation·Belma Füsun KöseoğluÖzge Ortabozkoyun
Jan 1, 2016·International Journal of Clinical and Health Psychology : IJCHP·Pia SchönfeldJürgen Margraf

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.